Inverse association between severe nausea and vomiting in pregnancy and some congenital abnormalities

American Journal of Medical Genetics

Volumn 140 A, Issue 5, 2006, Pages 453-462

  Czeizel, Andrew E ^a   Puhó, Erzsébet ^a   Ács, Nándor ^a   Bánhidy, Ferenc ^a  

^a NONE   (Hungary)

Author keywords

Congenital abnormalities; Nausea and vomiting during pregnancy; Population based case control study

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MALFORMATION; CLEFT LIP; CLEFT PALATE; CLUBFOOT; CONGENITAL HYDROCEPHALUS; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRYPTORCHISM; DISEASE SEVERITY; ESOPHAGUS ATRESIA; ESOPHAGUS STENOSIS; FEMALE; FIRST TRIMESTER PREGNANCY; GASTROSCHISIS; HUMAN; HUNGARY; HYPOSPADIAS; INTESTINE ATRESIA; INTESTINE STENOSIS; KIDNEY AGENESIS; LIMB MALFORMATION; MAJOR CLINICAL STUDY; MICROCEPHALY; NAUSEA AND VOMITING IN PREGNANCY; NEURAL TUBE DEFECT; POLYDACTYLY; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PYLORUS STENOSIS; SYNDACTYLY; UMBILICAL HERNIA; URINARY TRACT MALFORMATION; URINARY TRACT OBSTRUCTION;

ABNORMALITIES; ADULT; CARDIOVASCULAR ABNORMALITIES; CLEFT LIP; CLEFT PALATE; FEMALE; HUMANS; HUNGARY; INFANT, NEWBORN; INFORMATION SYSTEMS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MATERNAL AGE; NAUSEA; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; QUESTIONNAIRES; RISK FACTORS; URETHRAL OBSTRUCTION; VOMITING;

EID: 33644852805     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31097     Document Type: Article

References (40)

1. Appierto U, Subrizi DA, Minozzi M, Unfer V. 1996. Nausea, vomiting and thyroid function before and after induced abortion in normal pregnancy. Clin Exp Obstet Gynecol 23:18-20.
2. Biggs JS. 1975. Vomiting in pregnancy. Causes and management. Drugs 9:299-306.
3. Boneva RS, Moore CA, Botto L, Wong LY, Erickson JD. 1999. Nausea during pregnancy and congenital heart defects: A population-based case-control study. Am J Epidemiol 149:717-725.
4. Briggs MH. 1982. Hypospadias, androgen biosynthesis and synthetic progestogens during pregnancy. Int J Fertil 27:70-72.
5. Chin RKH. 1989. Antenatal complications and perinatal outcome in patients with nausea and vomiting-complicated pregnancy. Eur J Obstet Gynecol Reprod Biol 33:215-219.
6. Czeizel AE. 1997. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55:299-355.
7. Czeizel AE, Puhó E. 2004. Association between severe nausea and vomiting in pregnancy and lower rate of preterm birth. Paediat Perinatal Epid 18:253-259.
8. Czeizel AE, Vargha P. 2003. Case-control study of teratogenic potential of thiethylperazine, an antiemetic drug. Br J Obstet Gynec 110:497-499.
9. Czeizel AE, Vargha P. 2004. A case-control study of dimenhydrinate, an antiemetic drug use during pregnancy. Arch Gynec Obstet 274:638-642.
10. Czeizel AE, Rockenbauer M, Siffel Cs, Varga E. 2001. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 63:176-185.
11. Czeizel AE, Sárközi A, Wyszynski DF. 2003a. Protective effect of hyperemesis gravidarum for isolated oral clefts. Obstet Gynec 101:737-744.
12. Czeizel AE, Petik D, Vargha P. 2003b. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 12:409-416.
13. Czeizel AE, Puhó E, Bánhidy F, Ács N. 2004. Oral pyridoxine during pregnancy. Potential protective effect for cardiovascular malformations. Drugs R and D 5:259-269.
14. Einarson A, Koren G, Bergrman U. 1998. Nausea and vomiting in pregnancy: A comparative European study. Eur J Obstet Gynec Reprod Biol 76:1-3.
15. Fairweather DV. 1968. Nausea and vomiting in pregnancy. Amer J Obstet Gynecol 102:135-175.
16. Ferencz C, Rubin JD, Loffredo CA, Magee CA, (editors). 1983. Perspectives in Pediatric Cardiology. Epidemiology of congenital heart disease. Vol. 4. New York: Future Publishing Co., Inc. p 169-180.
17. Flaxman SM, Sherman PW. 2000. Morning sickness: A mechanism for protecting mother and embryo. Q Rev Biol 75:113-148.
18. Furneaux EC, Langley-Evans AJ, Langley-Evans SC. 2001. Nausea and vomiting of pregnancy endocrin basis and contribution to pregnancy outcomes. Obstet Gynecol Surv 56:755-782.
19. Golding J, Vivian S, Baldwin JA. 1983. Maternal anti-nauseants and clefts of lip and palate. Hum Toxicol 2:63-73.
20. Hook EB. 1987. Dietary cravings and adversions during pregnancy. Am J Clin Nutr 31:1355-1362.
21. Huxley RR. 2000. Nausea and vomiting in early pregnancy: Its role in placental development. Obstet Gynecol 95:779-782.
22. Jarnfelt-Samsioe A, Samsioe G, Velinder GM. 1983. Nausea and vomiting in pregnancy-A contribution to its epidemiology. Gynecol Obstet Invest 16:221-225.
23. Kauppila A, Heikinheimo M, Lohela H, Ylikorkala O. 1984. Human chorionic gonadotrophin and pregnancy-specific beta-1-glycoprotein in predicting pregnancy outcome and in association with early pregnancy vomiting. Gynecol Obstet Invest 18:49-53.
24. Klebanoff MA, Mills YL. 1986. Is vomiting during pregnancy teratogenic? Br Med J 292:724-726.
25. Kricker A, Ellio AJ, Forrest J, McCredie J. 1986. Congenital limb deficiency: Maternal factors in pregnancy. Aust N Zeel J Obstet Gynecol 26:272-275.
26. Kullander S, Källen B. 1976. A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet Gynecol Scand 55:105-111.
27. Masson GM, Anthony F, Chau E. 1985. Serum chorionic gonadotrophin (hCG), schwangerschaftsprotein 1 (SP1), progesterone and oestradiol levels in patients with nausea and vomiting in early pregnancy. Br J Obstet Gynaecol 92:211-215.
28. Medalie JH. 1957. Relationship between nausea and/or vomiting in early pregnancy and abortion. Lancet 273:117-119.
29. Medveczky E, Puhó E. 2004. Parental employment status and neural-tube defects and folic acid/multivitamin supplementation in Hungary. Eur J Obstet Gynec Reprod Biol 115:178-184.
30. Milkovich L, van den Berg BJ. 1976. An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 125:244-248.
31. Petitti DB. 1986. Nausea and pregnancy outcome. Birth 13:223-226.
32. Pirisi A. 2001. Meaning of morning sickness still unsettled. Lancet 357:1272.
33. Profet M. 1988. The evolution of pregnancy sickness as protection to the embryo against Pleistocene teratogens. Evol Theory 8:177-190.
34. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sørensen HT and EuroMAP group. 2001. Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 12:461-466.
35. Saxen I. 1975. Epidemiology of cleft lip with or without cleft palate. An attempt to rule out chance correlations. Br J Prev Soc Med 29:103-110.
36. Sherman PW, Flaxman SM. 2002. Nausea and vomiting of pregnancy in an evolutionary perspective. Am J Obstet Gynecol 186(Suppl 5):S190-197.
37. Tierson FD, Olsen CL, Hook EB. 1985. Influence of cravings and aversions on diet in pregnancy. Ecol Food Nutr 17:117-129.
38. Tsang IS, Katz VL, Wells SD. 1996. Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynec Obstet 55:231-235.
39. Weigel MM, Weigel R. 1989. Nausea and vomiting of early pregnancy and pregnancy outcome. An epidemiological study. Br J Obstet Gynaecol 96:1304-1311.
40. Yerushalmy J, Milkovich L. 1965. Evaluation of the teratogenic effects of medizine in man. Am J Obstet Gynecol 93:553-562.